Literature DB >> 19409931

Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract.

Manju Sharma1, Shawn A Anderson, Roland Schoop, James B Hudson.   

Abstract

Several viruses associated with upper respiratory diseases have been shown to stimulate the secretion of pro-inflammatory cytokines, including chemokines, sometimes in the absence of viral cytopathology. We evaluated the ability of a standardized preparation of the popular herbal medicine Echinacea (Echinaforce, an ethanol extract of herb and roots of E. purpurea, and containing known concentrations of marker compounds) to inhibit the viral induction of various cytokines in a line of human bronchial epithelial cells (BEAS-2B), and in two other human cell lines. All of the viruses tested, rhinoviruses 1A and 14, influenza virus, respiratory syncytial virus, adenovirus types 3 and 11, and herpes simplex virus type 1, induced substantial secretion of IL-6 and IL-8 (CXCL8), in addition to several other chemokines, depending on the virus, although only viable viruses were able to do this. In every case however Echinacea inhibited this induction. The Echinacea preparation also showed potent virucidal activity against viruses with membranes, indicating the multi-functional potential of the herb. These results support the concept that certain Echinacea preparations can alleviate "cold and flu" symptoms, and possibly other respiratory disorders, by inhibiting viral growth and the secretion of pro-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409931     DOI: 10.1016/j.antiviral.2009.04.009

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  32 in total

1.  In vitro antiviral, anti-inflammatory, and antioxidant activities of the ethanol extract of Mentha piperita L.

Authors:  YuXian Li; YiBo Liu; AiQin Ma; Yong Bao; Man Wang; ZhenLiang Sun
Journal:  Food Sci Biotechnol       Date:  2017-11-30       Impact factor: 2.391

2.  Evaluation of immunopathologic effects of aqueous extract of Echinacea purpurea in mice after experimental challenge with Pasteurella multocida serotype A.

Authors:  A Rezaie; D Gharibi; M Ghorbanpoor; S Anbari; M Pourmahdi Broojeni
Journal:  Iran J Vet Res       Date:  2014       Impact factor: 1.376

3.  Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.

Authors:  Travis V Gulledge; Nicholas M Collette; Emily Mackey; Stephanie E Johnstone; Yasamin Moazami; Daniel A Todd; Adam J Moeser; Joshua G Pierce; Nadja B Cech; Scott M Laster
Journal:  J Ethnopharmacol       Date:  2017-10-14       Impact factor: 4.360

4.  Traditional Medicine Practice in the Context of COVID-19 Pandemic: Community Claim in Jimma Zone, Oromia, Ethiopia.

Authors:  Belachew Umeta Chali; Tsegaye Melaku; Nimona Berhanu; Birhanu Mengistu; Gudina Milkessa; Girma Mamo; Sintayehu Alemu; Temesgen Mulugeta
Journal:  Infect Drug Resist       Date:  2021-09-16       Impact factor: 4.003

Review 5.  Echinacea for preventing and treating the common cold.

Authors:  Marlies Karsch-Völk; Bruce Barrett; David Kiefer; Rudolf Bauer; Karin Ardjomand-Woelkart; Klaus Linde
Journal:  Cochrane Database Syst Rev       Date:  2014-02-20

6.  Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.

Authors:  Ken Declerck; Claudina Perez Novo; Lisa Grielens; Guy Van Camp; Andreas Suter; Wim Vanden Berghe
Journal:  BMC Complement Med Ther       Date:  2021-05-12

7.  Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  M Jawad; R Schoop; A Suter; P Klein; R Eccles
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-16       Impact factor: 2.629

8.  Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds.

Authors:  Christopher Lupfer; Didier Besnouin; Samuel E Tepper; Maciej Maselko; Kristin M Patton; Manoj Pastey
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

9.  Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers.

Authors:  E Tiralongo; R A Lea; S S Wee; M M Hanna; L R Griffiths
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-20       Impact factor: 2.629

10.  Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV).

Authors:  Stephan Pleschka; Michael Stein; Roland Schoop; James B Hudson
Journal:  Virol J       Date:  2009-11-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.